Royal Pharmaceutical Society in England and the Royal College of General Practitioners have published recommendations for the roll-out and success of the
GP Community Pharmacist Consultation Service (GP CPCS).
These recommendations follow a workshop with stakeholders from pharmacy, general practice and representative bodies, examining ways to maximise the potential of the service and meet growing demand on the health service.
The workshop report made five recommendations:
The NHS England and Improvement should provide additional investment in local system support and resources to drive the CPCS implementation and uptake between
general practice and community pharmacy.
National representative bodies should work with NHS E&I to develop national and local engagement and streamline communication plans for CPCS referral pathway.
Focus on expanding the role of community pharmacists in the management of minor illness.
Evaluation of CPCS service and its impacts on general practice workload, patient outcomes and health inequalities.
The much-awaited Pharmacy First service has been launched in England, enabling patients to get treatment for seven common conditions from their community
pharmacists without needing to see a GP.
According to NHS England, a total of 10,265 community pharmacies, which is equivalent to more than nine in ten community pharmacies in the country, will be
offering the ground-breaking initiative.
The new scheme allows highly trained pharmacists to give advice and prescription-only medicines for minor ailments including sinusitis, sore throat, earache,
infected insect bite, impetigo, shingles, and uncomplicated urinary tract infections in women (under the age of 65).
With this major expansion of pharmacy services, the NHS is aiming to free up 10 million GP appointments a year while giving the public more choice in where and
how they access care.
To maximise the benefits of the Pharmacy First service for patients, the NHS, and community pharmacies, Community Pharmacy England (CPE) has advised the
community pharmacists to to establish a robust relationship between community pharmacies and local general practices.
The news comes after several reports highlighted issues regarding GP referrals for the seven minor ailment conditions under the Pharmacy First services.
According to the reports, many pharmacists claimed that "many GPs in England are not sending patients to them to be treated - and that some are refusing to
participate at all in the "groundbreaking" Pharmacy First scheme".
In response to foster better relationship with the GPs, CPE has said that strong local collaborations will enable general practice teams to confidently refer
patients to the Pharmacy First and other community pharmacy services where appropriate.
Moreover, the organisation emphasised implementation of long-term changes in practice will take time. The current focus on integrating GP referrals to Pharmacy
First will likely require sustained effort over several months or longer.
Recently, the English Health Secretary has talked about introducing a 'Pharmacy First' model similar to that which exists in Scotland. This would be a win-win
outcome providing people with better access to essential healthcare support, advice and treatment whilst relieving strain on other parts of the NHS, not least GPs
and A&E.
It is a no-brainer and yet despite a few media headlines there are still no firm proposals on the table to make this a reality. It surely cannot be right that you
can receive a broad range of patient care services in Scotland which are not available in England. It works well in Scotland, Wales is keen to develop more
pharmacy-based services and Northern Ireland, leaving aside the current funding dispute, has had a minor ailments service for many years.
If the English Health Secretary is sincere in his interest in adopting an English version of the Scottish model, then there are critical aspects he needs to
consider.
Firstly, start with the patient journey through the healthcare ecosystem from illness prevention through to long-term condition management. What is the role of
community pharmacy and how do we guide people to seek support from the most appropriate healthcare professional?
What is the vision for community pharmacy delivering patient care in the next decade?
The lesson from Scotland is that the government needs to sit down with the sector and map that out together. There are no quick fix overnight solutions. This needs
to be a long-term commitment backed by adequate funding. Supervision regulations need to change and there needs to be a thought through workforce strategy which
avoids community pharmacy shortages as that does nothing to deliver improved patient outcomes.